Research Article
Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients
Table 2
Clinical characteristics of patients with and without Biejia-Ruangan (BR) treatment in nonalcoholic cirrhosis.
| | | All patients (N=176) | | BR (N=63) | No-BR (N=113) | value |
| | Age, mean ± SD (range) (yr) | 50.8 ± 11.1 | 52.3 ± 10.3 | 0.745 | | Gender (m/f) | 37/26 | 66/47 | 0.967 | | Etiology of cirrhosis | 0.794 | | Hepatitis B | 49 | 87 | | | Hepatitis C | 6 | 8 | | | Autoimmune hepatitis | 6 | 11 | | | Unknown | 2 | 7 | | | Serum albumin (g/L) | 35.5 ± 5.1 | 35.8 ± 5.8 | 0.090 | | Decompensated cirrhosis | 45/18 | 87/26 | 0.414 | | K + (mmol/L) | 3.82 ± 0.39 | 3.95 ± 0.37 | 0.133 | | Child–Pugh class | 0.967 | | A | 45 | 81 | | | B | 15 | 27 | | | C | 3 | 5 | | | ALT (U/L) | 55.5 (29.2, 21.9) | 42.5 (23.5, 17.2) | 0.069 | | AST (U/L) | 54.5 (36.9, 39.9) | 58.4 (28.8, 18.9) | 0.084 | | Total bilirubin (mg/dL) | 32.4 (21.5, 21.6) | 33.8 (19.5, 14.3) | 0.408 | | Na + (mmol/L) | 140.7 ± 2.9 | 140.0 ± 3.6 | 0.716 | | INR | 1.26 (1.23, 0.25) | 1.30 (1.21, 0.33) | 0.982 | | Creatinine (μmol/L) | 64.7 (57.2, 20.5) | 64.9 (63.6, 17.2) | 0.130 | | Hemoglobin (g/L) | 121.9 ± 24.9 | 113.1 ± 23.2 | 0.396 | | Platelet (109/L) | 92.8 (73.3, 76) | 85.6 (60.0, 63.0) | 0.526 | | White blood cells (109/L) | 3.53 (3.15, 2.55) | 3.53 (3.28, 1.84) | 0.704 | | MELD | 10.9 (10.0, 5.0) | 10.6 (9, 4) | 0.389 |
|
|
Abbreviations: K+, potassium; Na+, sodium; ALT, alanine aminotransferase; AST, aspartate aminotransferase; INR, international normalized ratio; MELD, model for end-stage liver disease; BR, Biejia-Ruangan.
|
